JBF Capital’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,006
| Closed | -$369K | – | 78 |
|
|
2023
Q3 | $369K | Sell |
27,006
-23,044
| -46% | -$315K | 0.08% | 46 |
|
|
2023
Q2 | $1.02M | Hold |
50,050
| – | – | 0.21% | 26 |
|
|
2023
Q1 | $1.1M | Hold |
50,050
| – | – | 0.25% | 28 |
|
|
2022
Q4 | $819K | Sell |
50,050
-2,450
| -5% | -$40.1K | 0.2% | 26 |
|
|
2022
Q3 | $479K | Buy |
+52,500
| New | +$479K | 0.12% | 32 |
|